{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:41:26Z","timestamp":1792813286794,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.semarthrit.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T20:34:01Z","timestamp":1486586041000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["In-hospital mortality in febrile lupus patients based on 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome"],"prefix":"10.1016","volume":"47","author":[{"given":"Sung Soo","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Woo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Jungsik","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2017.02.002_bib1","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.semarthrit.2011.11.002","article-title":"Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s","volume":"41","author":"Mak","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-016-0571-2","article-title":"Mortality in systemic lupus erythematosus: an updated review","volume":"18","author":"Fors Nieves","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.hoc.2015.06.010","article-title":"Macrophage activation syndrome","volume":"29","author":"Ravelli","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/BOR.0000000000000093","article-title":"Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"26","author":"Weaver","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib10","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-114-5-387","article-title":"The acute lupus hemophagocytic syndrome","volume":"114","author":"Wong","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib12","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.24883","article-title":"Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients","volume":"60","author":"Parodi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3899\/jrheum.110639","article-title":"Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case\u2013control study and literature review","volume":"39","author":"Kim","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib14","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/art.38672","article-title":"Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults","volume":"66","author":"Kumakura","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib15","first-page":"1414","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9343(79)90633-8","article-title":"Fever in systemic lupus erythematosus","volume":"67","author":"Stahl","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/asheducation-2011.1.178","article-title":"Approach to hemophagocytic syndromes","volume":"2011","author":"Weitzman","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib19","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2017.02.002_bib20","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2007.078477","article-title":"Disease activity assessment in SLE: do we have the right instruments?","volume":"66","author":"Petri","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib21","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.110550","article-title":"Systemic lupus erythematosus disease activity index 2000 responder index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials","volume":"38","author":"Touma","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3899\/jrheum.141088","article-title":"SLEDAI-2K does not conceal worsening in a particular system when there is overall improvement","volume":"42","author":"Touma","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.02.002_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/ard.2010.132068","article-title":"An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA","volume":"70","author":"Isenberg","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T04:10:39Z","timestamp":1749960639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216303730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0049017216303730"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.02.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-hospital mortality in febrile lupus patients based on 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}